SciSparc (NASDAQ:SPRC) Trading Up 9.4% – What’s Next?

SciSparc Ltd. (NASDAQ:SPRC)’s share price was up 9.4% during trading on Thursday . The company traded as high as $5.40 and last traded at $5.36. 42,523 shares changed hands during mid-day trading, a decline of 1% from the average session volume of 43,100 shares. The stock had previously closed at $4.90.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of SciSparc in a research note on Tuesday, May 26th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock presently has a consensus rating of “Sell”.

SciSparc Stock Up 9.4%

The company’s 50 day simple moving average is $6.53 and its 200-day simple moving average is $6.56.

SciSparc (NASDAQ:SPRC) last announced its quarterly earnings results on Wednesday, April 29th. The company reported ($31.60) EPS for the quarter. The business had revenue of $0.20 million for the quarter.

SciSparc Company Profile

SciSparc AG is a clinical‐stage medical technology company focused on the development and commercialization of extracorporeal shock wave–based neuromodulation devices. Founded in 2016 and headquartered in Switzerland, the company applies proprietary low‐intensity shock wave technology to noninvasively stimulate neural tissue. SciSparc completed its initial public offering on the NASDAQ in 2021 under the ticker SPRC, securing funding to advance its clinical pipeline.

The company’s lead product, the TR100 system, delivers transcranial shock wave stimulation (tSWS) designed to target areas of the brain associated with motor control and cognitive function.